Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX

被引:163
作者
Beck, Tobias J.
Kreth, Friedrich W.
Beyer, Wolfgang
Mehrkens, Jan H.
Obermeier, Andreas
Stepp, Herbert
Stummer, Walter
Baumgartner, Reinhold
机构
[1] Univ Munich, Laser Res Lab, D-81377 Munich, Germany
[2] Univ Munich, Dept Neurosurg, D-81377 Munich, Germany
[3] Univ Dusseldorf, Dept Neurosurg, D-40225 Dusseldorf, Germany
关键词
neurosurgery; photodynamic therapy; stereotactic; interstitial; intratumoral; light application; brain tumor; glioblastoma; 5-aminolevulinic acid; protoporphyrin IX; cylindrical diffuser; dosimetry;
D O I
10.1002/lsm.20507
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and Objective: Limited knowledge of the light and temperature distribution within the target volume in combination with non-selective accumulation of the applied photosensitizers (PS) has hampered the clinical relevance of interstitial photodynamic therapy (iPDT) for treatment of malignant glioma patients. The current pilot study focused on the development and the clinical implementation of an accurate and reproducible irradiation scheme for iPDT using 5-aminolevulinic acid (5-ALA) induced protoporphyrin IX (PPIX) as a selectively working PS. Study Design/Materials and Methods: Monte Carlo simulations of fluence rate and heat transport simulations were performed using the optical properties of normal brain tissue infiltrated by tumor cells (absorption coefficient mu(a) = 0.2 cm(-1), reduced scattering coefficient: mu'(s) = 20 cm(-1)). A modified 3-D treatment-planning software was used to calculate both, the treatment-volume and the exact position of the light diffusers within the lesion. The feasibility and the risk of iPDT were tested in 10 patients with small and circumscribed recurrent malignant gliomas. Results: The optimum distance between the implanted light diffusers was determined to be 9 mm with regard to both fluence rate and temperature distribution. For this distance a temperature increase above 42 degrees C was not expected to occur. Up to six cylindrical light diffusers were stereotactically implanted to achieve a complete irradiation of the tumor volume, which was possible in every single patient (mean tumor volume: 5.9 cm(3)). The total applied light fluence was between 4,320 J and 11,520 J. Side effectsof iPDT were not observed. Median survival was 15 months. Conclusion: 5-ALA iPDT in combination with a 3-D treatment-planning (which was based on optical and thermal simulations) is a safe and feasible treatment modality. The clinical impact of these findings deserves further prospective evaluation.
引用
收藏
页码:386 / 393
页数:8
相关论文
共 45 条
[1]   EARLY POSTOPERATIVE MAGNETIC-RESONANCE-IMAGING AFTER RESECTION OF MALIGNANT GLIOMA - OBJECTIVE EVALUATION OF RESIDUAL TUMOR AND ITS INFLUENCE ON REGROWTH AND PROGNOSIS [J].
ALBERT, FK ;
FORSTING, M ;
SARTOR, K ;
ADAMS, HP ;
WILSON, CB ;
KUNZE, S ;
SALCMAN, M .
NEUROSURGERY, 1994, 34 (01) :45-61
[2]   REGROWTH PATTERNS OF GLIOBLASTOMA-MULTIFORME RELATED TO PLANNING OF INTERSTITIAL BRACHYTHERAPY RADIATION-FIELDS [J].
BASHIR, R ;
HOCHBERG, F ;
OOT, R .
NEUROSURGERY, 1988, 23 (01) :27-30
[3]   Clinical determination of tissue optical properties in vivo by spatially resolved reflectance measurements [J].
Beck, TJ ;
Beyer, W ;
Pongratz, T ;
Stummer, W ;
Waidelich, R ;
Stepp, H ;
Wagner, S ;
Baumgartner, R .
PHOTON MIGRATION AND DIFFUSE-LIGHT IMAGING, 2003, 5138 :96-105
[4]   Damage threshold of normal rat brain in photodynamic therapy [J].
Chen, Q ;
Chopp, M ;
Madigan, L ;
Dereski, MO ;
Hetzel, FW .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1996, 64 (01) :163-167
[5]   Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon - Comparison of continuous and fractionated light regimes [J].
Curnow, A ;
Haller, JC ;
Bown, SG .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2000, 58 (2-3) :149-155
[6]   NORMAL BRAIN-TISSUE RESPONSE TO PHOTODYNAMIC THERAPY - HISTOLOGY, VASCULAR-PERMEABILITY AND SPECIFIC-GRAVITY [J].
DERESKI, MO ;
CHOPP, M ;
CHEN, Q ;
HETZEL, FW .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1989, 50 (05) :653-657
[7]   Photodynamic therapy of actinic keratosis at varying fluence rates:: assessment of photobleaching, pain and primary clinical outcome [J].
Ericson, MB ;
Sandberg, C ;
Stenquist, B ;
Gudmundson, F ;
Karlsson, M ;
Ros, AM ;
Rosén, A ;
Larkö, O ;
Wennberg, AM ;
Rosdahl, I .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (06) :1204-1212
[8]  
Friesen SA, 2002, INT J ONCOL, V21, P577
[9]   Damage to tumour and brain by interstitial photodynamic therapy in the 9L rat tumour model comparing intravenous and intratumoral administration of the photosensitiser [J].
Hebeda, KM ;
Kamphorst, W ;
Sterenborg, HJCM ;
Wolbers, JG .
ACTA NEUROCHIRURGICA, 1998, 140 (05) :495-501
[10]   ALA- and ALA-ester-mediated photodynamic therapy of human glioma spheroids [J].
Hirschberg, H ;
Sun, CH ;
Tromberg, BJ ;
Madsen, SJ .
JOURNAL OF NEURO-ONCOLOGY, 2002, 57 (01) :1-7